Loading…

Corrigendum to 'Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials': [ESMO Open Volume 7, Issue 2, (2022), 100455]

Saved in:
Bibliographic Details
Published in:ESMO open 2022-06, Vol.7 (3), p.100494, Article 100494
Main Authors: König, D, Schär, S, Vuong, D, Guckenberger, M, Furrer, K, Opitz, I, Weder, W, Rothschild, S I, Ochsenbein, A, Zippelius, A, Addeo, A, Mark, M, Eboulet, E I, Hayoz, S, Thierstein, S, Betticher, D C, Ris, H-B, Stupp, R, Curioni-Fontecedro, A, Peters, S, Pless, M, Früh, M
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2059-7029
2059-7029
DOI:10.1016/j.esmoop.2022.100494